CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,813,971
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,813,971. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-05 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +107,500 | 107,500 | ||
| 2024-02-27 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −4,337 | $46.51 | $202K | 663 |
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −663 | $47.29 | $31K | 0 |
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 45,000 | ||
| 2023-09-06 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-09-06 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −4,994 | $54.76 | $273K | 6 |
| 2023-09-06 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −6 | $55.27 | $332 | 0 |
| 2023-09-06 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 50,000 | ||
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −4,672 | $66.95 | $313K | 328 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −328 | $67.95 | $22K | 0 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 55,000 | ||
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −3,966 | $67.98 | $270K | 1,034 |
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −1,034 | $68.69 | $71K | 0 |
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 60,000 | ||
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Exercise or conversion 10b5-1 | +15,000 | $13.53 | $203K | 20,000 |
Page 1 of 3 · 52 trades